Joe Saseen, PharmD: No financial relationships to disclose
Renin is from the renal system. The liver removes the “gin” from angiotensinogen. The lungs are laced with ACE, which converts I to II. Did this make sense to you? Join this session to get back to basics on the renin-angiotensin-aldosterone system (RAAS) and how evidence-based guideline recommended medications impact outcomes. Get a refresher on the cardiovascular and renal protective effects, as well as risks, of RAAS inhibitors!
Learning Objectives:
Describe how the renin-angiotensin-aldosterone system functions in the regulation of blood pressure and its downstream effects.
Explain the benefits and risks of RAAS inhibitors in regard to cardiovascular and renal protective effects.
Develop a treatment and monitoring plan to evaluate the efficacy and safety of RAAS inhibitors.
